Coagulation cascade

Hemodialysis International

Volumn 10, Issue SUPPL. 2, 2006, Pages

  Green, David ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Clotting factors; Coagulation; Microparticles; Platelets

Indexed keywords

BLOOD CLOTTING FACTOR 7A; ENZYME PRECURSOR; PADGEM PROTEIN; THROMBIN; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

BLOOD CLOTTING; CELL VACUOLE; CONFERENCE PAPER; EXPOSURE; FIBRIN FORMATION; MEMBRANE FUSION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RECEPTOR BINDING; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE MEMBRANE; VASCULAR ENDOTHELIUM;

BLOOD COAGULATION; DISEASE PROGRESSION; FACTOR VIIA; FIBRIN; HUMANS; P-SELECTIN; PLATELET ACTIVATION; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 33749352355     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2006.00119.x     Document Type: Conference Paper

References (12)

1. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation (review). Arterioscler Thromb Vasc Biol. 2002; 22: 1381-1389.
2. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 1989; 84: 92-99.
3. Wagner DD. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2005; 25: 1321-1324.
4. Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost. 2005; 3: 1590-1596.
5. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005; 106: 1604-1611.
6. Hugel B, Martinez MC, Kunzelmann C, Freyssinet J-M. Membrane microparticles: Two sides of the coin. Physiology. 2005; 20: 22-27.
7. Andre P, Denis CV, Ware J, et al. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood. 2000; 96: 3322-3328.
8. Altieri DC. Xa receptor EPR-1. FASEB J. 1995; 9: 860-865.
9. Monkovic DD, Tracy PB. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem. 1990; 265: 17132-17140.
10. Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost. 2001; 85: 958-965. (Also by these authors: Rethinking the coagulation cascade. Current Hematol Rep 2005; 4: 391-396. What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol. 2006; 26: 41-48).
11. Rawala-Sheikh R, Ahmad SS, Monroe DM, et al. Role of gamma-carboxyglutamic acid residues in the binding of factor IXa to platelets and in factor-X activation. Blood. 1992; 79: 398-405.
12. Gayle RB III, Maliszewski CR, Gimpel SD, et al. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest. 1998; 101: 1851-1859.